Literature DB >> 23949765

Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi.

Pedram Gerami1, Amy S Paller.   

Abstract

Linking phenotypic patterns of melanocytic neoplasia to specific gene mutations allows more precise predicting of clinical behavior and response to targeted therapy. In this issue, Kinsler et al. provide evidence that multiple congenital nevi with central nervous system lesions are likely exclusively the result of mosaic mutations in NRAS. We discuss the link between mosaic NRAS mutations, cellular senescence, and clinical phenotype in these nevi.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23949765     DOI: 10.1038/jid.2013.146

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

Review 1.  Somatic mosaicism: on the road to cancer.

Authors:  Luis C Fernández; Miguel Torres; Francisco X Real
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

2.  NRAS-mutated melanocytic BAP1-associated intradermal tumor (MBAIT): a case report.

Authors:  Willeke A M Blokx; Katrin Rabold; H Jorn Bovenschen; Marjolijn J L Ligtenberg; Arjen R Mensenkamp; Gesina van Lijnschoten; Wendy A G van Zelst-Stams; Patricia J T A Groenen
Journal:  Virchows Arch       Date:  2014-10-24       Impact factor: 4.064

3.  Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway.

Authors:  Dipanjan Basu; Cláudia M Salgado; Bruce S Bauer; Donald Johnson; Veronica Rundell; Marina Nikiforova; Yasmin Khakoo; Lorelei J Gunwaldt; Ashok Panigrahy; Miguel Reyes-Múgica
Journal:  Neuro Oncol       Date:  2015-09-09       Impact factor: 12.300

4.  Novel insights into the pathogenesis and treatment of NRAS mutant melanoma.

Authors:  Jeffrey Zhao; Carlos Galvez; Kathryn Eby Beckermann; Douglas B Johnson; Jeffrey A Sosman
Journal:  Expert Rev Precis Med Drug Dev       Date:  2021-08-11

5.  Topical therapy for regression and melanoma prevention of congenital giant nevi.

Authors:  Yeon Sook Choi; Tal H Erlich; Max von Franque; Inbal Rachmin; Jessica L Flesher; Erik B Schiferle; Yi Zhang; Marcello Pereira da Silva; Alva Jiang; Allison S Dobry; Mack Su; Sharon Germana; Sebastian Lacher; Orly Freund; Ezra Feder; Jose L Cortez; Suyeon Ryu; Tamar Babila Propp; Yedidyah Leo Samuels; Labib R Zakka; Marjan Azin; Christin E Burd; Norman E Sharpless; X Shirley Liu; Clifford Meyer; William Gerald Austen; Branko Bojovic; Curtis L Cetrulo; Martin C Mihm; Dave S Hoon; Shadmehr Demehri; Elena B Hawryluk; David E Fisher
Journal:  Cell       Date:  2022-05-12       Impact factor: 66.850

6.  Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis.

Authors:  Francis Shih; Stephen Yip; Patrick J McDonald; Albert E Chudley; Marc R Del Bigio
Journal:  Acta Neuropathol Commun       Date:  2014-10-21       Impact factor: 7.801

7.  NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study.

Authors:  Kuan-Jou Wu; Shu-Hao Li; Jia-Bin Liao; Chien-Chun Chiou; Chieh-Shan Wu; Chien-Chin Chen
Journal:  Biology (Basel)       Date:  2021-05-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.